Male Sex Enhancer Steroids Sildenafil Citrate Anabolic Steroid Hormones Viagra

Male Sex Enhancer Steroids Sildenafil Citrate Anabolic Steroid Hormones Viagra

Quick Detail:

Product name: Sildenafil Citrate
Alias: Sildenafil, Viagra
CAS No: 521-11-9
MF: C20H32O2
MW: 304.47
Purity: 99%
Dosage: 120-145 mg
Onset time: 30 minites
Half-life: 4 to 12 hours
Water solubility: Insoluble
Appearance: White powder, odorless, taste bitter and astringent insoluble in water and alcohol.
Function: Used in the treatment of penile erectile dysfunction (ED).


Description:

Sildenafil, sold as Viagra and other trade names, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. Its use for sexual dysfunction in women is not clear.

Common side effects include headaches and heart burn, as well as flushed skin. Caution is advised in those who have cardiovascular disease. Rare but serious side effects include prolonged erections, which can lead to damage to the penis, and sudden-onset hearing loss. Sildenafil should not be taken by people who take nitrates such as nitroglycerin, as this may result in a severe and potentially fatal drop in blood pressure.

It acts by inhibiting cGMP-specific phosphodiesterase type 5 (PDE5), an enzyme that promotes degradation of cGMP, which regulates blood flow in the penis.

It was originally discovered by Pfizer scientists Andrew Bell, David Brown, and Nicholas Terrett.[2][3] Since becoming available in 1998, sildenafil has been a common treatment for erectile dysfunction; its primary competitors are tadalafil (Cialis) and vardenafil (Levitra).


Applications:

Sexual dysfunction
The primary indication of sildenafil is treatment of erectile dysfunction (inability to sustain a satisfactory erection to complete intercourse). Its use is now standard treatment for erectile dysfunction including for those with diabetes mellitus.

Pulmonary hypertension
As well as erectile dysfunction, sildenafil citrate is also effective in the rare disease pulmonary arterial hypertension. It relaxes the arterial wall, leading to decreased pulmonary arterial resistance and pressure. This, in turn, reduces the workload of the right ventricle of the heart and improves symptoms of right-sided heart failure. Because PDE5 is primarily distributed within the arterial wall smooth muscle of the lungs and penis, sildenafil acts selectively in both these areas without inducing vasodilation in other areas of the body. Pfizer submitted an additional registration for sildenafil to the United States Food and Drug Administration (FDA), and sildenafil was approved for this indication in June 2005. The preparation is named Revatio, to avoid confusion with Viagra, and the 20-mg tablets are white and round. Sildenafil joins bosentan and prostacyclin-based therapies for this condition.

Permanent link: http://www.vvchem.com/sell/cas:521-11-9,3319022.html